Elsevier

Pediatric Neurology

Volume 9, Issue 2, March–April 1993, Pages 140-143
Pediatric Neurology

Case report
Neonatal glycine encephalopathy: Biochemical and neuropathologic findings

https://doi.org/10.1016/0887-8994(93)90051-DGet rights and content

Abstract

A patient with neonatal glycine encephalopathy who had severe neurologic retardation, spasticity, and seizures died at 17 years of age. Glycine concentration was markedly elevated in brain tissue, especially in the cerebellum. Neuropathologic study revealed spongy myelinopathy throughout the central nervous system and calcium oxalate crystals in the cerebellum, which are probably derived from degradation of glycine. Myelinopathy appeared to be static compared to neonatal patients. The neurologic manifestations of neonatal glycine encephalopathy are probably due to neurotransmitter abnormalities, not to myelin damage.

References (15)

There are more references available in the full text version of this article.

Cited by (15)

  • Uremic encephalopathy

    2022, Kidney International
    Citation Excerpt :

    The importance of these neurotransmitters has been demonstrated in several nonuremic encephalopathies. Glycine is linked to neonatal and childhood encephalopathies, while in hepatic encephalopathy, similar changes in branched amino acids and glutamate occur as in uremic encephalopathy.58–61 These amino acids do not conform to the classical definition of “uremic toxins,”62 as the data for glycine and glutamate do not unequivocally point to accumulation in CKD while circulating branched chain amino acids are decreased.63–69

  • Amino Acids

    2018, Volpe's Neurology of the Newborn
  • X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid

    2017, Pediatric Neurology
    Citation Excerpt :

    The progression over the entire internal capsule and posterior white matter restricted diffusion and decreased apparent diffusion coefficient values (Fig 2) has also been observed in NKH but not in cblC/D patients.9,10 Neuropathologically, this MRI pattern can correspond to a vacuolating myelinopathy whereby myelinated areas undergo spongiosis with microcysts resulting in restricted diffusion, as observed in NKH.11 However, no molecular genetic confirmation was found for AMT, GLDC, or GCSH.

  • Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy

    2008, Brain Research Reviews
    Citation Excerpt :

    AIDS vacuolar myeloneuropathy is histopathologically almost indistinguishable from Cbl-Df leukoneuropathy (Di Rocco et al., 2002). Spongy vacuolation of CNS white matter is not specific to Cbl-Df leukoneuropathy, but also occurs in the CNS white or gray matter of different human and experimental diseases (e.g. glycine leukoencephalopathy (Agamanolis et al., 1993), encephalopathies caused by some retroviruses (Lynch et al., 1991) and prion proteins (Prusiner, 2001), some mitochondriopathies (Sparaco et al., 1993), and vanishing white matter (VWM) disease (van der Knaap et al., 2006)). We will only consider some key points concerning the difference between the CNS lesions of acquired Cbl deficiency and those of inherited Cbl disorders (named from cblA to cblH) (Rasmussen et al., 2001; Whitehead, 2006).

View all citing articles on Scopus
View full text